A lumiüol-dependent non-opsonized zymosan-induced chemiluminescence method for phagocytes in small quantities of whole blood (40 ; final dilution: l : 14) is described. It was characterized with reference to cellular and humoral components, and also applied to isolated neutrophils, eosinophils and monocytes. Normal values for whole blood chemiluminescence and for neutrophils, eosinophils and monocytes are presented. From the chemiluminescence characteristic of distinct phagocytes and their frequency distribution pattern in whole blood, it is concluded that whole blood chemiluminescence has its source predominantly in neutrophils. The question äs to the origin of chemiluminescence in phagocytes of whole blood and isolated neutrophils is investigated. The results support the importance of the myeloperoxidase-H 2 O 2 -halide System, but also go beyond this. The release of arachidonic acid by phospholipase A 2 and of diacylglycerol and inositol trisphosphate by phospholipase C, the metabolism of arachidonic acid by the cyclooxygenase and lipoxygenase pathway, the activation of membrane NADPH oxidase by diacylglycerol and the calcium mobilisation by inositol trisphosphate are necessary for the chemiluminescence reaction. Inhibition of either mechanism suppresses the chemiluminescence response. The interaction of non-opsonized zymosan with plasma opsonins, phagocyte Fc-and complement receptors, respectively, for the initiation of chemiluminescence, was investigated. Non-opsonized zymosan initiates a chemiluminescence response in blood phagocytes in the absence of opsonin from the interaction of the zymosan polysaccharide component glucan with the complement receptor type 3. In the presence of plasma this receptor type also mediates the major chemiluminescence response brought about by the zymosan-coated cleavage products of complement fraction three, iC3b and to a minor degree G3b, while immunoglobulin G-coated zymosan interaction with the Fcreceptor is in this case of minor importance.
'
Q uc.On Superoxide anion (Öi), hydrogen peroxide (H 2 O 2 ), \ Upon interaction with particulate Stimuli or chemical and probably hydroxyl radical (· OH) and singlet s Stimulation, polymorphonuclear Jeuköcytes (neutro-oxygen (* 2 ) (1). These excited oxygen species react philic and eosinophilic granulocytes), monocytes and with certain biological Substrates to become electronimacrophages respond with a chain of biochemical cally excited products which generate light upon rei and cytophysioiogical events commonly known äs laxation. The relatively poor quantum yield of this ' the respirätory burst native chemiluminescence can be increased more than a thousand fold by using cyclic hydrazides such äs This respiratory burst is characterized by an increase ^.^ as ^ bystander substra te. in glucose dehydrogenation via the hexose monophosphate shunt and a non-mitochondrial increase Many investigators have employed luminol-enhanced in oxygen consumption. By enzymatic and non-en-chemiluminescence of isolated polymorphonuclear zymatic reactions, oxygen is largely converted into leukocytes to measure their oxygenation capacity or, with a constant granulocyte concentration and variable amounts of plasma, the opsonic capacity of plasma (2) .
The high sensitivity of chemilummogenic probing, however, allows measurement of phagocyte oxygenation activity using diluted native whole blood (see I.e. (l, 2) for examples). The numerous cellular and humoral components which modulate and contribute to the chemiluminescence response of whole blood, have not, however, been well defined. In the first part of our work the influence of plasma and of erythrocytes äs well äs the contribution of phagocytes other than neutrophilic granulocytes were investigated separately. Normal values for chemiluminescence in whole blood and isolated blood cells (neutrophils, eosinophils, monocytes) were established.
The second part of our work contributes to the ongoing controversy concerning the origin of zymosaninduced luminol-dependent chemiluminescence.
The myeloperoxidase H 2 O 2 -halide system, seen äs responsible in the generation of singlet oxygen and hypochlorous acid for chemiluminescence in activated neutrophils (3) was recently challanged by Cheung et al. (4) who postulated that the metabolism of arachidonic acid via the lipoxygenase and cyclooxygenase pathway is the source of chemiluminescence.
We investigated the influence of supplemented Superoxide dismutase, catalase and myeloperoxidase, of metabolic Inhibitors and of scavengers of reactive oxygen species on chemiluminescence in whole blood and isolated neutrophils.
It was concluded that the interaction between the NADPH oxidase system and arachidonic acid metabolism generates chemiluminescence but that each System alone does not.
In the last part of our study we examined the importance of ligand-receptor-mediated initiation of chemiluminescence in phagocytes.
Efficient interaction between phagocytes and particles requires the participation of opsonins, serüm proteins such äs inimunoglobulin G, and the opsonic fragments of complement factor three (C3) which become attached to the surface of microorganisms or other particles and interact with specific receptors on phagocytic cells (5, 6) . For zymosan there are conflicting results regarding its interaction with certain cell types, even in the absence of opsonins (5, 7) .
We investigated the initiation of chemiluminescence in whole blood and isolated neutrophils with opsonincoated zymosan and non-opsonized zymosan äs well äs the influence of chemicals and antibodies directed against specific opsonins or against distinct complement receptor types on the phagocyte membrane. Our results shöw that all blood cell phagocytes can interact with zymosan via chemiluminescence response without any opsonin. From this study and the published evidence available, a onodel suggesting the origin of non^opsonized zymosan-induced and luminol-enhanced chemiluminescence in whole blood and neutrophils is presented.
Materials and Methods
Chemicals, media and reagents Sigma Chemicals Co., Louis, USA: Zymosara A from Saccharomyces cerevisiae; N-fonnyl-1-L-methionyl-L-leucyl-L-phenylalanine (f-Met-Leu-Phe); catalase (EC 1.11.1.6) from bovine liver (2890 U/mg); nordihydroguaiaretic acid; indometacin; benzoic acid (sodium salt); dimethyl sulphoxide; quinacrme; arachidonic acid from porcine liver; dibütyryl cAMP; theöphyk line; N-acetyUZ^glucosämine; human immunoglobulin G; antihuman complement C 3 ; anti-human immunoglobulin G (whole molecule); prostaglandin E t ; prostaglandin E 2 .
Boehringer Mannheim GmbH, FRG: Luiniiiol dihydro-1. 
Erythrocytes
Erythrocytes were banded at the bottom on the two-step discontinuous Percoll gradient. They were recovered and washed once in phosphate buffered saline. As the density of erythrocytes and polymorphonuclear cells overlap (10), the erythrocytes were again centrifuged on 4ml Percoll with p = 1.0945 kg/l. After this the erythrocytes were washed twice in phosphate-buffered saline and resuspended in Minimal Essential Medium to a haematocrit of 0.50. The erythrocytes were essentially free of polymorphonuclear cells.
Chemiluminescence
Chemiluminescence assays in whole blood and isoiated blood cells were performed on a Biolumat 9505 with a six channel device interconnected with an Apple He, a floppy disk II, a video display and an Epson MX 82F/T printer (Laboratorium Prof. Dr. Berthold, Wildbad, FRG) in polystyrene chemiluminescence vials at 37 °C.
Standard assay

Luminol
Luminol (22.6 mmol/1) was prepared daily in Minimal Essential Medium containing triethylamine (40 mmol/1). Luminol final assay concentration: 0.4 mmol/1.
'Non-opsonized zymosan
Zymosan particles were washed twice in phosphate buffered saline, resuspended in Minimal Essential Medium to 100 g/l and stored frozen at -70°C in small aliquots. Zymosan final assay concentration: 3.5 g/l.
Pipetting scheine see page 768
Modification of the chemiluminescence Standard assay % In order firstly to optimize the assay and secondly to study the humoral and cellular aspects of whole blood and isoiated cell chemiluminescence, the following modifications and additions were made.
Mononuclear cells and monocytes
Blood cells, depleted fr m platelet-rich plasma, were centrifuged on the two-step discontinuous Percoll gradient described for polymorphonuclear cells. Mononuclear cells were harvested from the top of the upper layer, washed twice in phosphatebuffered saline and resuspended in Minimal Essential Medium. Monocytes were identified by esterase staining. The fraction of monocytes in the mononuclear cell Suspension ranged from 0.17 to 0.26 (χ ± SD: 0.23 ± 0.03). The monocyte concentration was adjusted to 1-2 χ 10 6 /ml in Minimal Essential Medium irrespective of the total mononuclear concentration. It has been demonstrated that the chemiluminescence activity of mononuclear cells is due to the monocytes and not to lymphocytes (11) . Contamination with polymorphonuclear cells was less than 1%.
Eosinophils
Human eosinophils are denser than neutrophils, but the r nge of densities of the two cell types overlap. However, if neutrophils are exposed to the chemotactic peptide f-Met-Leu^Phe, which d es not stim iate eosinophils, the neutrophil density decreases, shifting them away from the density of eosinophils (12) . Wh ie blood (4ml)i which had been exposed for 15 min at 37 °C tp the chemotactic peptide f-Met-Leu-Phe at 10" 6 mol/1, was added to a three Step discontinuous gradient of each 3 ml stock isoosmotic Percoll diluted with sodium Chloride (0.15 mol/1) to p = 1.0945 kg/l, 1.0808 kg/l and 1.0779 kg/l and processed s described in the section "polymorphonuclear cells". The cell layer between the interface of both l wer density concentrations was harvested, washed twice in phosphate-buffered saline and the cell count adjusted to 1-2 χ 10 6 /ml in Minimal Essential Medium. After Pappenheim staining, purity was 77%.
Luminol
The final assay concentration of luminol ranged from 0.04 mmol/1 to 2 mmol/1. Various volumes of luminol were balanced with different volumes of Minimal Essential Medium. Whole blood volume (40 μΐ) and non-opsonized zymosan (20 μΐ) were constant.
Zymosan
The final assay concentration of non-opsonized zymosan ranged from 0.35 g/l to 35 g/l. Various volumes of non-opsonized zymosan were balanced with different volumes of Minimal Essential Medium. Whole blood volume (40 μΐ) and luminol (10 μΐ) were constant.
In some experiments (see tab. 4) opsonized zymosan was used. Zymosan, washed with phosphate-buffered saline (100 g/l), was incubated with normal human pooled plasma at 37 °C for 30 min, washed twice in phosphaterbuffered saline, resuspended in Minimal Essential Medium to 100 g/l and stored frozen at -70 °C in small aliquots. Opsonized zymosan final assay concentration: 3.5 g/l. 
Red blood cells
Plasma composition
Two experiments were performed to investigate the role of plasma in whole blood chemiluminescence and in chemiluminescence of isolated neutrophils. Methodological procedure and results are presented in table l and table 2. Addition of Superoxide dismutase, myeloperoxidase and catalase Superoxide dismutase, myeloperoxidase and catalase were dissolved in and diluted with Minimal Essential Medium to give final assay catalytic activity concentrations of 400 k /1, 200 U/l and 4800 kU/1, respectively. Experiments were performed with whole blood and isolated neutrophils. Whole blood experiments included the Standard assay procedure with non-opsonized zymosan and also opsonized zymosan and plasma-depleted whole blood (washing three times) with opsonized zymosan. Experiments with neutrophils followed the same scheme. All enzymes were incubated with whole blood or neutrophils, in the presence of luminol in Minimal Essential Medium for 5 min at 37 °C; reaction was initiated with non-opsonized or opsonized zymosan. Results are expressed s the quotient of chemiluminescence peak maximum values (CL l-K 1) in the presence and in the absence of enzymes (tab. 4).
Addition of metabolic inhibitors and scavengers of reactive oxygen species
Nordihydroguaiaretic acid was dissolved in dimethylsulphoxide to 10 mmol/1 and further diluted in Minimal Essential Medium. Final assay concentration: 0.1 mmol/1. Dimethylsulphoxide has been reported to be a hydroxyl radical scavenger (4). Our control experiments showed, however, that the amount of dimethylsulphoxide we used did not affect the magnitude of the chemiluminescence response. Arachidonic acid and prostaglandin Et and £ 2 were dissolved in ethanol to 30.6 mmol/1 and 2.8 mmol/1, respectively, and further diluted in Minimal Bssential Medium. Final assay concentration: 0.05 mmol/1 and 0.03 mmol/1, respectively. All other drugs were dissolved in Minimal Essential Medium. Final assay concentration in brackets: Lalanine (10.5 mmol/1); £-mannitol (40 mmol/1); sodium benzoate (1.5 mmol/1); L-histidine (21 mmol/1); sodium azide (l mmol/1); cyanide (l mmol/1); indometacin (l mmol/1); quinacrine (l mmol/1); dibutyryl cAMP (l mmol/1); theophylline (2 mmol/1); NaF (20 mmol/1); chloφΓomazine (0.1 mmol/1).
All drugs were incubated with whole blood or neutrophils in the presence of luminol in Minimal Essential Medium for 10 min at 37 °C; reaction was initiated with non-opsonized zymosan. Results are expressed s the quotient of chemiluminescence peak maximum values (CL l -K 1) in the presence and in the absence of inhibitors or scavengers (tab. 5).
Receptor studies N-acetyl-/>-glucosamine (200 mmol/1) and EDTA (3 mmol/1) were incubated with neutrophils or whole blood for 10 min at 37 °C before the Start with non-opsonized zymosan according to the Standard procedure. Autologous plasma (20 μΐ) or immunoglobulin G solution (20 μΐ of 11 g/l) are the source of particular opsonins in the experiments with isolated neutrophils. Among opsonins, complement C 3 , complement C 3b and immunoglobulin G were inhibited with anti-human complement C 3 , anti-human complement C 3b and anti-human immunoglobulin G (whole molecule), respectively, and with a combination of anti-immunoglobuHn G and anti-complement C 3 . Appropriate dilutions of plasma and immunoglobulin G solution with antibodies were prepared according to the titre, s given by the manufacturer. The monoclonal antibody OKM l final assay concentration was 5 mg/1.
Results
Optimizatipn of whole blood chemiluminescence; reference values
Luminol
With different luminol concentrations peak maximum is reached between 0.3 to 0.5 mmol/1 final assay concentration (not sh wn). In furthef experiments a luminol final assay concentration of 0.4 mmol/1 was used.
Non-opsonized zymosan
A steady increase of photon emission was observed with increasing zymosan particle concentration (not shown). In further experiments a non-opsonized zymosan final assay concentration of 3.5 g/l was usecL With increasing numbers of red blood cells, peak maximum values are drastically reduced, whereas time peak values remain unchanged.
Erythrocytes
Plasma volume
On the other band, if the numbers of erythrocytes and neutrophils are kept constant in an increasing plasma volume, the peak maximum increases and the peak time values become shorter ( fig. 2) .
Plasma volume and erythrocytes
Different combinations of plasma and red blood cells in a given constant volume of 40 μΐ with a constant number (0.5 χ l O 5 ) of neutrophils confirm both previous experiments. A shift to a higher volume fraction of erythrocytes against a lower volume fraction of plasma diminishes peak maximum counts and lengthens peak time ( fig. 3 ). Figure 4 demonstrates that a proportional dependency exists between whole blood peak maximum val es and granulocyte number. It is therefore possible to calculate a standardized chemiluminescence peak maximum for any blood sample, based on a fixed number f granulocytes. tndividual peak time values are also unchanged (not shown). As each of the five probands has a different original whole blood granulocyte number to which additional granulocytes were added, a conaprehensive graphical representation of peak time mean val es is not possible. 
Granulocytes
Plasma composition
Washing of whole blood and readj stmeiit to its initial haemqglobin cpncentration with autologous plasma does not alter the pverall chemiluminescence response (tab. 1). On the other band, Substitution of plasma by buffer solution, by complement C 3b -inactivated plasma (30 min 56 °C) or by complement C 3 b-desorbed plasma (100 mg zymosan per ml plasma, 30 min 37 °C) reduced the chemiluminescence response and shortened peak time values. Complement fraction C 5a alone without non-opsonized zymosan, is therefore not a potent Stimulus for the L C n. Chem. Clin. Biochem. / Vol. 25,1987 / No. 11 chemiluminescence response. These results contradict in the plasma fraction or its depletion from plasma those obtained for peak time values using isolated by zymosan desorption results in diminished chemilugranulocytes (tab. 2). Complement C 3b inactivation nainescence but lengthens peak time.
Tab. 1. Chemiluminescence in untreated whole blood and in artificial whole blood whose plasma component has been replaced or treated in various ways s shown in the scheine. Peak maximum (CL l, K 1; l O 3 counts/min χ 2 χ ΙΟ 5 granulocytes) and peak time (min) are given s mean ± SD; n = 11. n.d.: no clear cut peak time.
. Tab. 2. Chemiluminescence in isolated granulocytes with the addition of plasma treated in various ways s shown in the scheme.
Peak maximum (CL 1, K 1; 10 3 counts/min χ 0.5 χ ΙΟ 5 granulocytes) and peak time (min) are given s mean ± SD; n = 6. a reduced response Tor isolated neutrophils. To clarify the degree of contribution of naturally occurring plasma cnzymcs, Stimulation with opsonized, äs well äs non-opsonized zymosan and the effect of addition or withdrawal of plasma were studied.
Metabolie Inhibitors and scavengers of reactive oxygen species
When phagocytes in whole blood or isolated neutrophils were subjected to the inhibitory effects of alanine (scavenger of HC1O), mannitol and sodium benzoate (scavengers of hydroxyl radical) and histidine (scavenger of singlet oxygen) (4, 13), the most apprcciable effect was observed for sodium benzoate. Azide, known to be an inhibitor of haem enzymes like catalase and myeloperoxidase (l3), totally suppressed chemiluminescence, whereas cyanide, which additionally inhibits Superoxide dismutase had only a moderate inhibitory effect (tab. 5).
Inhibitors of arachidonic acid metabolism are very powerful inhibitors of the chemiluminescence response. Nordihydroguaiaretic acid was used to inhibit the lipoxygenase pathway (4), indometacin to inhibit the cyclooxygenase pathway (4), and quinacrine to inhibit arachidonic acid production from membrane phospholipids, presumably by phospholipase A 2 Inhibition (14) .
When arachidonic acid, the Substrate for both the lipoxygenase and the cyclooxygenase pathways was added, a small inhibitory effect was observed. Intracellular cAMP, which inhibits phosphoinositide turnover in human neutrophils (l 5), was raised by preincubation eithcr with dibutyryl cAMP and/or theophylline (15), with prostaglandins or with NaF (4). It was found that all agents effectively suppressed the chemiluminescence response.
Inhibition of the ubiquitious calcium-binding protein calmodulin, using chlorpromazine (16), largely diminished chemiluminescence in both whole blood and isolated neutrophils.
Receptor studies N-acetylglucosamine and EDTA have been reported to inhibit complement rcceptor type thrce mcdiated unspecific binding to non-opsonized zymosan and to C 3b fragment coated zymosan and to have no detcctable effect on complement receptor type one or Fcreceptors (5). In our chemiluminescence assay EDTA blocked almost every response, irrespective of the particular opsonin added to the isolated neutrophils or the naturally occurring and generating opsonins in whole blaod.
N-acetylglucosamine also effectively reduced the chemiluminescence response. In contrast to the above mentioned specificity, however, it also affects the Fcreceptor mediated response, äs becomes evident from the results using immunoglobulin G äs the specific opsonin. Anti-imnnunoglobulin G had no effect on isolated neutrophils when plasma (i.e. mainly IgG and nascent C 3b ) served äs opsonins. This contrasts markedly with the response found in the whole blood assay. Anti-complement C 3 , on the other band, has a greater reducing effect in the neutrophil assay with plasrna äs the source of opsonins than in the whole blood assay. Anti-complement C 3b is without any significant effect. A variety of monoclonal antibodies, including OKM l, recognize a cell surface molecule on phagocytes and it is suggested that this cell surface antigen is the iC 3b receptor (5, 6). In the case of chemiluminescence, however, OKM l caused only slight Inhibition in the whole blood assay and in the assay with isolated neutrophils with plasma äs the opsonin source.
Discussion
Optimization of whole blood chemiluminescence; normal values for whole blood and isolated phagocytes
Dilutions of whole blood in the final assay mixture in reported methods for whole blood chemiluminescence ränge from l : 5 to l : 8000 (see I.e. (l, 2)). In our System blood is finally diluted 1:14. If quantitation of phagocyte-specific oxygenation activity is the sole objective of testing, relatively high dilutions of blood are needed. A t a whole blood dilution of l : 8000 to peak maximum nearly equals that of isolated granulocytes (1). Photon yield is drastically reduced with increasing erythrocyte haemoglobin concentration ( fig. 1 ). The peak maximum of whole blood phagocytes is only about 0.05 of that for an equivalent number of isolated granulocytes (tab. 3). There are three possible reasons for this phenomenoii. Firstly, most of this decrease could be a physical consequence of photon absorption by haemoglobin (1). Secondly, erythrocytes serve äs potent scävengers of activated oxygen species in vivo (17, 18) and in vitro (13) . Thirdly, compared with isolated granulocytes, whole blood phagocytes possess distinctly fewer type l and type 3 complement receptors, both in the resting state, and after Stimulation by activating Stimuli (6), and they thus alter the activation profile. The importance of cell surface receptors on phagocytes and of plasma opsonins is discussed in detail below.
It is generally accepted, that lymphocytes and thrombocytes do not directly contribute to zymosan4n-duced chemiluminescence (11).
The relatively identical activation characteristic of granulocytes, i. e. neutrophils and eosinophils and the wer peak maximum values for stimulated monocytes (tab. 3) has, on the whole, been confinned in comparative studies with eosinophils vs. neutrophils (19) and monocytes vs. neutrophils (20) . Neutrophils, eosinophils and monocytes account for 0.87, 0.04 and 0.09, respectively, of the phagocytes in normal blood. According to the Stimulation and distribution pattern of phagocytes, it is concluded that whole blood chemiluminescence is mainly the response of neutrophils. This is strengthened by the fact that proportional dependency exists between whole blood peak maximum values and granulocyte number (flg. 4). This is the basis for expressing whole blood chemiluminescence on the basis of a constant cell number, i dent of other cellular and humoral impjications.
Addition of Superoxide dismutase, myelop eroxidase, catalase and of Metabolie inhibitors and scavengers of reactive oxygen species Luminol-dependent chemiluminescence seenis to be completely linked with a reaction liiediated by the myeloperoxidase*H2O2-halide System, whereäs native luminol-independent chemiluminescence is also related to a not yet elucidated O 2 -mediated reaction (3, (21) (22) (23) . These two obviously different mechanisms should be distinguished from one another, äs well äs the Stimulation with distinct particulate or söluble agents. Cheung et al. (4), however, postulated that the lipöxygenase (and cyclooxygenase) pathway is the source of zymosan-induced and luminol-enhanced chemiluminescence.
It should be clearly stated that only the mechanism of zymosan-stimulated luminol-dependent chemiluminescence is ünder discussion here. That the reactive oxygen species alone are the>source of chemiluminesĉ ence is contradicted by the following observatioils:
1. Superoxide dismutase and catalase cannot completely inhibit chemiluminescence, regardless of the quantity of inhibitors used (3, 4) . We even find augmented chemiluminescence in whole blood upon addition of catalase (tab. 4). This must be dtie to some, until now unexplained, prpperties of the weak erythrocyte chemiluminescence response (24).
2. Previous studies have revealed that the excited oxygen species are principally capable of oxidizmg luminol (23) . Nevertheless, the magnitude of response is minimal and the time course very fast compared with zymosan-activated neutrophils (3, 4) . This observation has led to the general comment that these oxidizing agents are not by themselves sufficient for light emission (4). Superoxide dismutase, myeloperoxidase, catalase) only slight or moderate Inhibition was observed. Sodium benzoate (scavenger of hydroxyl radical) and azide (inhibitor of catalase and Superoxide dismutase) are more powerful (tab. 5). In luminol-dependent chemiluminescence Systems the effect of scavengers and inhibitors of reactive oxygen species is hard to evaluate. Scavenging, quenching and inhibitory effects overlap and contradictory results have been obtained. The relative importance of these oxygen species äs the source of chemiluminescence has been reported very differently (3,4, 23) .
However, in addition to the importance of the myeloperoxidase-H 2 O 2 -halide hypothesis (3, 22) , which is supported by our results from myeloperoxidase addition (tab. 4), it is evident from our inhibitor studies of arachidonic acid metabolism that this pathway plays a central role in the chemiluminescence phenomenon.
In the present study we find that established inhibitors of the cyclooxygenase (indometacin) and lipoxygenase pathway (nordihydroguaiaretic acid) almost totally inhibit zymosan-induced chemiluminescence in whole blood and isolated neutrophils. Both substances have been reported to inhibit chemiluminescence in a dose-dependent manner, the latter being stronger (4, 25, 26) . From these experiments alone, however, it cannot be deduced whether light emissions is directly or indirectly attributed to the cyclooxygenase or lipoxygeiiase pathway.
However, arachidonic acid metabolism alone via the cyclooxygenase and/or lipoxygenase pathway is probably not the source of zymosan-induced chemiluminescence. This is supported by the observation that neutrophils from patients with chronic granulomatous disease do not respond with zymosan-induced luminol-enhanced chenüliroinescence, although the cells are able to metabolize arachidonic acid but lack the membrane NADPH oxidase and do not produce oxygen species (24, 26) . Nevertheless, there are several lines of evideüce which Support the notion that arachidonic acid metabolism has a pivotäl fole to play in chemiluminescence generation. Quinacrine, an inhibitor of arachidonic acid production from membrane phospholipids presumably by phospholipase A 2 Inhibition (4), totally suppresses zymosan* induced chemiluminescence. Other inhibitors of arachidonic acid metabolism are reagents which, by a different mode of action, lead to elevated leyels of cAMP, lifce theophylline and/or dibutyryl cAMP, prostaglandins and NaF (4, 15) . The agents mainly affect neutrophil response by inhibiting the phosphoinositide cycle (4, 15) . It has been reported that agonist-induced phosphoinositide Splitting äs well äs resynthesis are reduced by procedures aimed at increasing intracellular cAMP (15) . A third mode of action on the neutrophil response is obtained with a treatment aimed at modulating the calcium concentration by inhibiting the calcium-binding protein calmodulin with chlorpromazine. The action of chlorpromazine has been reported äs Inhibition of the activity of the calcium-dependent protein kinase C, phospholipase A 2 and the NADPH oxidase (16) .
A possible sequence of events leading to the generation of chemiluminescence by the interaction between the NADPH oxidase System and arachidonic acid metabolism is schematically presented in fig. 5 . It is based on the results of the present study and additionally inspired and supported by the reports of Cheung et al. (4), Bianca et al. (15), Phillips et al. (27) , Müller et al. (28) and Waite (29) . The zymosan-induced membrane pertubation leads to the activation of phospholipase C and phospholipase A 2 by a binding protein which, until now, has remained unidentified. A large propörtion of arachidonic acid released is derived from phosphatidylinositol, mediated by a calcium-dependent phospholipase C mechanism, and from phosphatidylcholine, suggesting a calcium-dependent phospholipase A 2 mechanism that could also explain the release from phosphatidylinositol. In order for arachidonate to be derived from the phospholipase C pathway a lipase must act on the diacylglycerol. The products of phospholipase C action, diacylglycerol and inositol trisphosphate have important actions without directly entering the arachidonate cascade. The latter is responsible for the mobilization of calcium from intracellular Stores and the opening of plasma membrane calcium channels. Diacylglycerol activates protein kinase C. The activation is associated with a translocation of cytosol protein kinase C in the plasma membrane which, in turn, activates NADPH oxidase by phosphorylation of some component of the oxidase. Decrease of diacylglycerol, brought about by cAMP, suppresses NADPH oxidase activation i. e. it suppresses chemiluminescence under our experimental conditions. The oxygen free radicals and their intermediates act mainly äs oxidants inside and outside the cell but are not sufficient for light emission. Arachidonic acid is oxidized via the cyclooxygenase and lipoxygenase pathway to prostaglandins, thromboxanes and hydroperoxyeicosatetraenoic acids and leukotrienes, respectively. These pathways are also insufficient for light emission. Although the mechanism of interaction between the NADPH oxidase System and arachidonic acid metabolism is not yet understood, it clearly multiplies the response enormously. Jr. Lx .
[N-acetylglucosamine EDTA OKM1 | Opsonins, receptors Two main observations are relevant here:
1. Human blood phagocytes respond with chemiluminescence on interaction with zymosan and luminol in the absence of opsonins, and 2. the chemiluminescence is more evident if zymosan particles become coated with fragments of the third component of cpmplement. These two aspects will be discussed separately. by zymosan particles via the alternative pathway (5-7). We will discuss the rolc of opsonins and thc role of cell surface receptors separately.
Opsonins
Results from depletion and omission of plasma, and physical trcatment which affects the third complement fraction and/or immunoglobulin G permit the conclusion that C 3 -derivcd fragments on zymosan are the major opsonic component; immunoglobulin G is of minor importance. The complement-independent chemiluminesccnce rcsponse is triggcred by the opsonin-independent glucan polysaccharide component of zymosan.
The results of chemical treatment with specific antibodics dirccted against C 3 , C 3b and immunoglobulin G, respectively have to be diflerentiated (tab. 6). The results with anti-immunoglobulin are critical for several reasons. Firstly, even highly purified immunoglobulin G with a negligible number of polymers induces a dose-dependent Stimulation of neutrophils s measured by chemiluminescence (31) . Secondly, soluble immunocomplexes are potent activators of the chemiluminescence response (32) . We also observed that the chemiluminescence with immunoglobulin G alone, without zymosan, is 0.3 of that measured for the immunoglobulin G-opsonized zymosan-induced response (absolute values from tab. 6, not shown). Naturally occurring immunoglobulin G from plasma, however, in the samc concentration r nge, obviously does not respond in this way (tab. l, tab. 3). This qualifies the values on antiimmunoglobulin G from tab. 6. The Inhibition studies with complement antibodies (tab. 6) indicate that iC 3b fixed on zymosan promotes the main chemiluminescence response. C 3b is of minor importance.
Cell surface receptor
It has been suggested that complement reccptor type 3 binds to both fixed iC 3b and non-opsonized zymosan i.e. the glucan component, and should bc inhibitcd by eithcr EDTA or N-acetylglucosamine (5, 7) . EDTA blocks the chemiluminescence response in whole blood and from isolated neutrophils more completely than N-acctylglucosamine (tab. 6). Thc effect of both inhibitors with immunoglobulin G s opsonin is essentially not mcdiated by an effccl on Fc-receptors, because the dccrease is mainly in thc non-opsonized zymosan-mediated rcaction. The latter has already been discussed to be dependcnl on complement receptor type 3 binding. These results again confirm our conclusion regarding the secondary importance of immunoglobulin G s opsonin for zymosan-mediated chemiluminescence.
Several monoclonal antibodies including OKM 1 recognize a cell surface moleculc on neutrophils, and it is suggested that the antigen recognized by these antibodies is the iC 3b receptor CR 3 (5-7), although blocking of the chemiluminescence response with OKM 1 was not very pronounced in our experiments (tab. 6).
With regard to this, there appears to be a contradiction in the finding that in whole blood the peak time is shortened by treatments affecting complement factor type 3 (tab. 1), whereas it lengthens in the assay with isolated cells (tab. 2, tab. 3); a common feature was thc feduction of peak maximum values.
It has been shown that granulocytes in whole unseparated blood express relatively few receptors for C 3b (CR 1) or iC 3b (CR 3) but substantially more on isolated granulocytes. Isolated cells continue to respond to Stimuli by furthcr increasing membrane expression Tab. 6. Influence on neutrophil and whole blood chemiluminescence by chemicals which react with surface membrane receptors on phagocytes or with opsonins. Results are cxpressed s quotients of chemiluminescence peak maximum values (CL l -K l, CL 2-K 2) in the presence and in the absencc of these chemicals. Final assay concentration for N-acetylglucosaminc, EDTA and OKM l were 200mmol/l, 3 mmol/1 and 5 mg/1, respectively. Antisera were diluted according to thc titre. Neutrophils (0.5 χ ΙΟ 5 ) or whole blood (40 μΐ) were incubated with the chemicals according to the Standard pipctting schemc in the material and methods section. Chemiluminescence was initiated with non-opsonized zymosan. In addition to the Standard procedure with autologous plasma (20 μΐ), immunoglobulin G (20 μΐ of a 11 g/l solution) serves s specific opsonin and phosphate-bufTered saline s control without any opsonin. χ ± SD of six to cight paired experiments. of these receptors to a greater extent than whole blood granulocytes. These additional receptors are likely to be translocated from an intracellular pool to the surface (6), thus lengthening the peak time value (tab. l vs. tab. 2, tab. 3). It is advisible, therefore, to draw only very cautious conchisions aboüt whole blood or even in vivo conditions ffom observations made on isolated cells.
